Search Results "#POMCDeficiency"

Blogs

arrow_forward View More Results
Proopiomelanocortin Deficiency Treatment Market: How Is Setmelanotide Therapy Becoming the Fastest-Growing Therapeutic Intervention?
Posted by Surbhi on July 24 2026 at 05:41 PM   public
Setmelanotide (IMCIVREE) — the first FDA-approved melanocortin-4 receptor (MC4R) agonist specifically indicated for proopiomelanocortin (POMC) deficiency-associated obesity representing the targe...
arrow_forward